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Integrating artiﬁcial with natural cells to translate
chemical messages that direct E. coli behaviour
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Previous efforts to control cellular behaviour have largely relied upon various forms of genetic
engineering. Once the genetic content of a living cell is modiﬁed, the behaviour of that cell
typically changes as well. However, other methods of cellular control are possible. All cells
sense and respond to their environment. Therefore, artiﬁcial, non-living cellular mimics could
be engineered to activate or repress already existing natural sensory pathways of living cells
through chemical communication. Here we describe the construction of such a system. The
artiﬁcial cells expand the senses of Escherichia coli by translating a chemical message that
E. coli cannot sense on its own to a molecule that activates a natural cellular response. This
methodology could open new opportunities in engineering cellular behaviour without
exploiting genetically modiﬁed organisms.
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S
ynthetic biology thus far has relied upon the engineering of
new cellular function through the insertion and deletion of
genetic information in living cells. This genetic engineering
based approach has progressed rapidly. There is now available a
set of well-characterized biological parts1–3 that can be used to
build complex genetic circuitry within and between the living
cells4–6. Further, entire genomes can be edited7 and synthesized8,
suggesting that fully designed organisms with heretofore unseen
capabilities are likely in the future.
Despite the wide range of technologies and target pathways
exploited, the desire to control microorganisms to date has always
employed direct genetic intervention. The limitations of these
prevalent methods are due to the difﬁculties of engineering living
systems, including evolutionary pressures that may alter engi-
neered pathways over time and the potential long-term
consequences of altering ecosystems with engineered organisms.
However, it may not be necessary to genetically modify living
cells. Extant life is already extremely complex, endowed with
numerous sensory and metabolic pathways tuned by billions of
years of evolution to be efﬁciently responsive to changing
intracellular and extracellular conditions. A simple change in
pH, for example, results in the up and downregulation of nearly
1,000 genes in Escherichia coli9. In other words, cells are already
capable of sensing many different stimuli and capable of
performing many tasks. Therefore, it should be possible to
exploit these existing cellular pathways to control cellular
behaviour without changing the genetic makeup of the cells.
Here we explore this idea of engineering E. coli through
alternative means by targeting the sensory pathways of E. coli. To
do so without altering the genetic content of the bacterium, we
instead construct artiﬁcial cells that could interact with natural
cells in order to evoke a behavioural response. The artiﬁcial cells
in this system function as chemical translators that sense
molecules that E. coli alone cannot sense. In response, the
artiﬁcial cells release a molecule that E. coli can naturally respond
to, thereby translating an unrecognized chemical message into a
recognized chemical message. In this way, the sensory capabilities
of E. coli are expanded without altering the genetic content of the
bacterium. The artiﬁcial cell is built with a phospholipid vesicle
containing isopropyl b-D-1-thiogalactopyranoside (IPTG), DNA,
and transcription–translation machinery. The DNA template
codes for a previously selected riboswitch that activates transla-
tion in response to the presence of theophylline10. The
theophylline riboswitch controls the synthesis of the pore
forming protein a-hemolysin (aHL). Therefore, in the presence,
but not the absence, of theophylline a pore forms that releases
entrapped IPTG. E. coli alone does not respond to theophylline,
and IPTG does not cross the vesicle membrane of the artiﬁcial cell
in the absence of the pore. The ability of E. coli to receive the
chemical message sent by the artiﬁcial cells is assessed in two
ways. First, the ﬂuorescence of E. coli carrying a plasmid encoding
a ﬂuorescent protein behind an IPTG-responsive, lac operator
sequence is evaluated. Second, the gene expression of
untransformed E. coli is monitored by reverse transcription
quantitative PCR (RT–qPCR). To our knowledge, this is the ﬁrst
artiﬁcial, cell-like system capable of translating unrecognized
signals into a chemical language that natural cells can recognize.
The integration of artiﬁcial translator cells with natural cells
represents a new strategy to introduce synthetic features to a
biological system while circumventing the need for direct genetic
manipulation.
Results
The theophylline-sensing device is functional in vitro. To build
artiﬁcial cells that sense theophylline and in response release
IPTG (Fig. 1), a theophylline-sensing genetic device was built
with a T7 transcriptional promoter, a theophylline riboswitch and
a gene encoding a fusion between aHL and super folder GFP at
the carboxy terminus. If functioning properly, this arrangement
should result in the expression of protein and thus green ﬂuor-
escence only in the presence of theophylline. However, cell-free
expression in the presence and absence of theophylline showed
similar levels of ﬂuorescence (Fig. 2a). Since this same riboswitch
was previously shown to function in vitro11, the sequence of the
aHL-GFP gene was more closely examined. Multiple pairs of
potential ribosome binding sites (RBS) and start codons were
identiﬁed within the aHL portion of the gene that were in-frame
with the GFP-encoding region. The theophylline riboswitch
controls translation, meaning that sequences behind the
theophylline riboswitch are always transcribed. Translation
from the RBS within the riboswitch is activated by direct
binding of theophylline to the messenger RNA. Therefore, if
additional sequences outside of the riboswitch but within the aHL
portion of the gene were recognized by the ribosome, then
regardless of the theophylline concentration, the expression of
truncated peptide products with ﬂuorescently active GFP would
have been possible. To test if such internal RBSs were present, the
theophylline riboswitch and thus the RBS preceding the aHL-
GFP sequence was deleted. In vitro transcription–translation of
this construct showed the accumulation of ﬂuorescence over time
similar to the riboswitch containing construct (Fig. 2b). Sequence
analysis revealed three potential RBS-start codon pairs within the
aHL coding portion of the gene. Of these, a putative RBS of
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Figure 1 | Artiﬁcial cells translate chemical signals for E. coli. (a) In the absence of artiﬁcial cells (circles), E. coli (oblong) cannot sense theophylline.
(b) Artiﬁcial cells can be engineered to detect theophylline and in response release IPTG, a chemical signal that induces a response in E. coli.
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AAAGAA was selected as the most likely candidate for giving
ﬂuorescent protein expression based on sequence composition
and spacing12. The putative internal RBS was removed by
mutation to TCTACC, resulting in a carboxy-terminal GFP
tagged K30S E31T aHL construct. Fluorescence from this
mutated construct was reduced threefold, consistent with the
removal of an internal RBS (Fig. 2b). Finally, K30S E31T aHL-
GFP was placed behind the theophylline riboswitch to test the
activity of the cell-free sensing device. A clear difference was
observed between protein expression in the presence and absence
of theophylline (Fig. 2c), and the ﬂuorescence arising in the
absence of theophylline was within 20% of the construct lacking
an RBS upstream of the full gene. The data were consistent with a
functioning riboswitch sensor with background ﬂuorescent
protein expression arising from internal RBS within aHL.
Therefore, the ﬁnal artiﬁcial cellular mimic described below was
built with aHL lacking a GFP-tag to avoid complications arising
from the expression of truncated ﬂuorescent protein product.
Active aHL is produced in response to theophylline in vitro. To
ensure that the cell-free expressed aHL was active as a pore, the
ability of aHL to degrade rabbit red blood cells was assessed
through a standard haemolysis assay13. Each construct was
expressed in vitro at 37 C for 6 h after which, an aliquot was
removed and added to red blood cells. Haemolysis was quantiﬁed
by measuring attenuance at 650 nm. In the presence of
theophylline, 90% haemolysis was observed when the genetic
construct containing a riboswitch-controlled aHL was expressed.
The cell-free expression of the same construct in the absence of
theophylline gave haemolysis levels similar to the negative control
reactions (Fig. 2d), as was expected for a functioning theophylline
riboswitch that controls the production of aHL. Control reactions
with commercial aHL-puriﬁed protein and in vitro-expressed
aHL and aHL–GFP all were fully active (Fig. 2d, Supplementary
Table 2), whereas aliquots from in vitro-expressed GFP alone
and aHL with a carboxy-terminal His-tag were inactive
(Supplementary Table 2). aHL with a carboxy-terminal His-tag
was previously shown to have reduced activity14. Also,
comparison of the riboswitch activity ﬂuorescence data with the
haemolysis assay data was consistent with the production of GFP
containing protein fragments from an internal RBS without an
active aHL domain. For example, the aHL–GFP construct lacking
one of the putative internal RBSs failed to produce protein with
haemolysis activity (Supplementary Table 2), despite giving rise
to ﬂuorescence during in vitro transcription–translation (Fig. 2b).
Artiﬁcial cells can translate chemical messages for E. coli. After
demonstrating that the riboswitch was able to control the in vitro
expression of aHL in response to theophylline and that the
expressed aHL molecules formed functional pores, the compo-
nent parts were next assembled inside of phospholipid vesicles to
build artiﬁcial cells. Theophylline is capable of passing through
the membrane of vesicles11. Phospholipid vesicles were generated
in the presence of IPTG, transcription–translation machinery and
DNA encoding aHL under the control of the theophylline
riboswitch. The vesicles were then puriﬁed by dialysis at 4 C to
remove unencapsulated molecules. The receiver bacterial cells
were mid-exponential phase E. coli BL21(DE3) pLysS carrying a
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Figure 2 | In vitro characterization of the theophylline-sensing device and aHL. (a) The cell-free expression of aHL–GFP behind a theophylline riboswitch
gives rise to similar levels of ﬂuorescence both in the presence (þ theo) and absence ( theo) of theophylline at 37 C. (b) The removal of the theophylline
riboswitch and thus, the RBS preceding the start codon of aHL–GFP shows production of a ﬂuorescent protein product when incubated with transcription–
translation machinery ( RBS). The removal of a putative internal RBS within the aHL coding portion of the fusion construct signiﬁcantly decreases the
production of the ﬂuorescent protein product (RBS mutant). (c) The activity of the theophylline-sensing device is observable by ﬂuorescence when an
internal RBS is removed. The top and middle curves are the in vitro expression of aHL–GFP behind the theophylline riboswitch in the presence (þ theo) and
absence of theophylline ( theo), respectively. Background ﬂuorescent protein production is shown with the same construct lacking the theophylline
riboswitch (RBS mutant) used in b. (d) The cell-free expression of theophylline riboswitch-controlled aHL-degraded red blood cells (RBCs) in the
presence (þ theo) but not the absence of theophylline ( theo). Control reactions include the expression of an aHL construct lacking the theophylline
riboswitch (aHL) and RBCs alone (negative control). RBC degradation was monitored by attenuance at 22 C. The exploited constructs were SP011A for
panel A, SP002A and AS014A for panel B, RL069A and AS014A for c, and RL067A and JF001A for d (Supplementary Table 1). Data are averages of three
independent reactions.
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plasmid encoding GFP behind a T7 promoter and a lac operator
sequence. In this commonly exploited system, IPTG induces the
expression of a chromosomal copy of T7 RNA polymerase in
E. coli BL21(DE3) and derepresses the expression of GFP from
the plasmid. Background expression is typically low with such an
arrangement because of the presence of constitutively expressed
lysozyme from pLysS, a natural inhibitor of T7 RNA polymerase.
To test if the artiﬁcial cells could function as chemical
translators for E. coli, the artiﬁcial cells were incubated with
E. coli BL21(DE3) pLysS carrying the GFP-encoding plasmid at
37 C, and the ﬂuorescence of E. coli was evaluated by ﬂow
cytometry. A control reaction in which theophylline was directly
added to E. coli in the absence of artiﬁcial cells failed to show
green ﬂuorescence after 3 h (Fig. 3a). Similarly, IPTG loaded
vesicles that did not contain the machinery necessary to form
pores did not induce ﬂuorescence in E. coli. Therefore, theophyl-
line was not able to induce a detectable response in E. coli, and
IPTG could not cross the vesicle membrane in the absence of
aHL, which was consistent with permeability measurements
(Supplementary Fig. 1). However, when E. coli was incubated
with artiﬁcial cells and theophylline, 17±10% and 69±3% of the
bacteria ﬂuoresced green after 0.5 and 3 h, respectively. When the
same experiment was repeated in the absence of theophylline,
3±1% and 24±5% of the bacteria were ﬂuorescent after 0.5 and
3 h, respectively (Fig. 3a,b). Longer incubations resulted in
diminishing differences between the two samples suggesting the
presence of low levels of aHL expression in the absence of
theophylline. Also, the GFP response was encoded within a
medium copy number plasmid. Therefore, higher background
levels of GFP were to be expected in comparison with gene
expression from the chromosome. The ﬂow cytometry experi-
ments were consistent with the ability of artiﬁcial cells to translate
an unrecognized chemical signal (theophylline) into a signal
(IPTG) that E. coli could respond to.
Although the artiﬁcial cells were capable of communicating
with E. coli, the induction of GFP synthesis, as observed above,
exploited an engineered response. To assess whether artiﬁcial
cells could elicit a natural, chromosomally encoded response,
RT–qPCR was used to measure gene expression from the lac
operon of E. coli. The lac operon is one of the most thoroughly
characterized sensory pathways15. The presence of allolactose (or
the non-hydrolyzable analogue IPTG) induces the expression of
lacZ, lacY and lacA. To facilitate detection of E. coli responding to
the chemical message sent from the artiﬁcial cells, E. coli BL21
(DE3) pLysS were grown in LB supplemented with glucose to
decrease the background expression of the lac operon and then
transferred to M9 minimal media prior to incubation with
artiﬁcial cells. The artiﬁcial cells were prepared as described for
the GFP induction experiments above. After incubating together
artiﬁcial cells with E. coli in the presence and absence of
theophylline for 4 h, aliquots were collected for RNA isolation.
The RNA was then reverse transcribed and lacZ, lacY, and lacA
expression quantiﬁed by qPCR. The RNA isolated from bacteria
incubated with artiﬁcial cells plus theophylline showed on average
over 20-fold higher lacZYA expression than samples incubated
with artiﬁcial cells alone (calculated from AC/(ACþ theo) as
shown in Fig. 3c). Taken together, the data are consistent with the
ability of artiﬁcial cells to translate chemical messages and induce
both engineered and natural pathways in E. coli.
Discussion
Direct genetic engineering of living cells is not needed to control
cellular behaviour. It is possible, instead, to coerce desired activity
through communication with artiﬁcial cells. The foundation for
such technologies has already been laid by both cell-free and
in vivo studies. Engineered communication paths between living
cells have been constructed to coordinate cellular activities in
response to external stimuli6,16 and are being developed for
therapeutic purposes17. In these systems, sender cells often can
process information and in response release molecules that affect
other cells. What has been shown herein builds on these past
efforts but does so by integrating reconstituted, non-living
systems with living cells. This allows for the genetic engineering
component of the system to be moved from the living, evolving,
replicating cells to the more controllable, ephemeral artiﬁcial
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Figure 3 | The artiﬁcial translator cells are functional. (a) Artiﬁcial cells can induce the expression of a plasmid encoded gene within E. coli in response to
a molecule that E. coli cannot naturally sense. BL21(DE3) pLysS carrying a plasmid encoding GFP behind a lac operator sequence was incubated with the
following components at 37 C for 3 h: theophylline (theo), artiﬁcial cells (AC), artiﬁcial cells plus theophylline (ACþ theo), IPTG encapsulated inside of
vesicles (encapsulated IPTG), and unencapsulated IPTG (IPTG). E. coli ﬂuorescence was quantiﬁed by ﬂow cytometry. The reported averages and s.e.m.
were calculated from three separate reactions run on three different days from independently assembled artiﬁcial cells. (b) A histogram of a subset of the
FACS data used in panel a shows a clear shift in the E. coli population in the presence of artiﬁcial cells plus theophylline. (c) Artiﬁcial cells can induce the
expression of chromosomally encoded genes of E. coli. After 4 h of incubation of artiﬁcial cells with E. coli at 37 C, the messenger RNA encoding lacZ, lacY
and lacA was quantiﬁed by RT–qPCR. Data are reported as averages of three measurements and error bars represent s.e.m.
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cells. When the artiﬁcial cells degrade, the natural cells go back
to their original state, thereby diminishing the possibility
of unintended long-term consequences. For example, rather
than engineering bacteria to search for and clean up
environmental contaminants, artiﬁcial cells could be built to
sense the contaminant molecules and in response release
chemoattractants that bring natural bacteria capable of feeding
on the contaminants18 to the affected site.
Several recent reports have described the engineering of seek-
and-destroy bacteria for the eradication of tumours or bacterial
infections19–22. However, these methods ultimately rely on
administering living bacteria to the patient. Artiﬁcial cells could
be built to carry out similar tasks if the sensor module of the
artiﬁcial cell was designed to detect the chemical conditions
associated with the ailment. For instance, rather than spraying
engineered bacteria into the lungs of cystic ﬁbrosis patients,
artiﬁcial cells could be built to detect the presence of
Pseudomonas aeruginosa bioﬁlms through the quorum
signalling molecules that are naturally secreted by the organism,
such as N-(3-oxododecanoyl)-L-homoserine lactone, a molecule
capable of crossing membranes without the aid of transporters.
Subsequently, the artiﬁcial cells could release small molecules, for
example, D-amino acids23, to disperse the bioﬁlm and thus clear
the infection. Moreover, the use of dispersion rather than killing
would decrease the probability of the bacteria developing
resistance. Similar strategies with artiﬁcial cells could be
developed to substitute for engineered probiotics that integrate
with gut microbiota24 and prevent disease25,26.
There are several limitations to these ﬁrst generation artiﬁcial
cells. First, heterogeneity in membrane lamellarity and in
encapsulation efﬁciency27 results in a mixture of artiﬁcial cells
with varying degrees of activity. Microﬂuidic-based methods for
compartment formation and solute encapsulation would likely
alleviate many of the complications associated with vesicle-to-
vesicle and batch-to-batch variability. Also, a system fully
dependent upon the permeability properties of the membrane
limits the types of molecules that can be sensed and released.
The development of speciﬁc membrane-associated sensors and
transporters will likely be necessary as the complexity of artiﬁcial
cells increase. Finally, the simple release of encapsulated
molecules means that release could result from compartment
degradation as opposed to an engineered response to the
detection of a speciﬁc molecule. It is, therefore, important to
develop an output that is mediated by synthesis so that
compartment degradation would only result in the release of
inactive starting molecules. An example of such a system is the
biological nanofactory described by Fernandes et al.28 that
synthesizes a signalling molecule from S-(50-deoxyadenosin-50)-
L-homocysteine via two enzymatic steps.
The absence of a living chassis opens up greater opportunities
to assemble or biofabricate various mechanisms or functions that
would be difﬁcult to implement with living cells. For example,
chemical systems housed within inorganic and peptide-based
compartments are capable of sensing the environment through,
in part, the gating behaviour of the non-lipid compartment29,30.
Further, artiﬁcial cells can synthesize and release signalling
molecules sensed by living cells without exploiting genetically
encoded parts31,32. The possibility of merging advances with non-
genetically encoded and genetically encoded parts may lead to the
construction of artiﬁcial cells that are better able to imitate
natural cellular life33,34.
Methods
Genetic constructs. The gene encoding Staphylococcus aureus aHL was synthe-
sized by Genscript. Super folder GFP (BBa_I746916) was from the registry of
standard biological parts (http://parts.igem.org). The theophylline riboswitch
sequence was from Lynch and Gallivan10 and was ampliﬁed from a previously
described construct11. All genes were subcloned into pET21b (Novagen) with NdeI
and XhoI restriction sites. Mutagenesis was performed by Phusion site-directed
mutagenesis (Thermo Scientiﬁc). All constructs were conﬁrmed by sequencing at
Genechron or Euroﬁns MWG Operon. Sequences of all the exploited constructs are
listed in Supplementary Table 1. All experiments were repeated at least three times.
Data are reported as averages with standard error, or representative runs are
shown.
In vitro characterization of the riboswitch. Plasmids were ampliﬁed in E. coli
Novablue (Novagen) and puriﬁed with Wizard Plus SV Minipreps DNA Pur-
iﬁcation System (Promega). Plasmid DNA was phenol–chloroform extracted,
ethanol precipitated and resuspended in deionized and diethyl pyrocarbonate-
treated water. PCR products were puriﬁed with Wizard Plus SV Gel and PCR
Clean-Up Systems (Promega). Transcription–translation reactions used the
PURExpress In Vitro Protein Synthesis Kit (New England Biolabs) supplemented
with 20 units of Human Placenta RNase Inhibitor (New England Biolabs). Reac-
tions were monitored by ﬂuorescence with a CFX96 Touch real-time PCR (Bio-
Rad) using the SYBR green ﬁlter set.
a-hemolysin activity. Each construct was expressed with the PURExpress In Vitro
Protein Synthesis Kit at 37 C in a ﬁnal volume of 25 ml either in the presence or
absence of 1.5mM theophylline for 6 h. Rabbit red blood cell (RBC) suspensions
(adjusted to D¼ 0.1 at 650 nm) were added to a microplate where the reaction
mixtures were serially diluted. Changes in attenuance of the RBC suspension were
measured at 650 nm with a microplate reader (UVmax, Molecular Devices) for
30min at 22 C as reported in Laventie et al.35 The results are reported as
percentage of haemolysis or as the time necessary to reach 50% of haemolysis.
Preparation of E. coli receiver cells. Mid-exponential E. coli BL21(DE3) pLysS
transformed with a plasmid encoding super folder GFP behind a T7 promoter and
a lac operator sequence (CD101A12) were grown in LB supplemented with
100 mgml 1 ampicillin and 34mgml 1 chloramphenicol to an optical density of
0.5 at 600 nm. A quantity of 200ml aliquots in 10% (vol/vol) glycerol were ﬂash
frozen with liquid nitrogen and stored at  80 C for later use. Aliquots were
rapidly thawed and mixed with 2ml LB supplemented with 100 mgml 1 ampicillin
and 34 mgml 1 chloramphenicol and incubated for 2 h at 37 C with 220 r.p.m.
shaking. Finally, the cells were gently pelleted and resuspended in 1ml M9 minimal
media.
Preparation of artiﬁcial cells. Vesicles were prepared as previously described36,37.
Brieﬂy, 12.5mg 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and
12.5mg cholesterol (Avanti Polar Lipids) in chloroform were mixed in a round
bottom ﬂask. A thin lipid ﬁlm was made through rotary evaporation with a Buchi
Rotovapor R-210 equipped with a Buchi Vacuum Pump V-700 for 5 h. A quantity
of 2ml DEPC-treated deionized water was then added to the thin lipid ﬁlm and
vigorously vortexed. The resulting liposome dispersion was homogenized with an
IKA T10 basic homogenizer at a power setting of 4 for 1min. A quantity of 100ml
aliquots were frozen in liquid nitrogen or dry ice and lyophilized overnight in a
vacuum concentrator (Centritrap DNA concentrator, Labconco) at 40 C. The
lyophilized empty liposomes were stored at  20 C. A quantity of 100ml aliquots
of freeze-dried liposomes were hydrated with 25 ml of 100mM IPTG (Sigma)
dissolved in 50mM HEPES pH7.6, 25 ml of the PURE system, 500 ng DNA and 20
units of human placenta RNase inhibitor (ﬁnal volume of 50 ml), unless otherwise
noted. Solutions were gently mixed for 30 s.
To remove extravesicular material, the vesicles were dialyzed following a
method previously described by Zhu and Szostak38. The original membranes of
500 ml Slide-a-Lyzer dialysis cassettes (Pierce) were exchanged with 25mm
diameter polycarbonate track-etched membranes with a 1 mm pore size
(Whatman). A quantity of 50ml of unpuriﬁed vesicles were loaded onto the center
of the dialysis system with a 100ml Hamilton syringe and dialyzed against 250ml of
buffer A (50mM HEPES, 10mM MgCl2, 100mM KCl, pH 7.6) with stirring. The
ﬁrst four rounds of dialysis were for 10min each. Two more rounds of dialysis in
which the buffer was changed after 30min incubations were further performed. All
dialysis steps were carried out at 4 C.
Artiﬁcial–natural cell communication. Puriﬁed vesicles containing DNA, the
PURE system, and IPTG were incubated with E. coli BL21(DE3) pLysS trans-
formed with CD101A in M9 minimal media supplemented with 1mgml 1 of
Proteinase K and 5mM theophylline at 37 C in a ﬁnal volume of 40 ml. Control
reactions did not contain theophylline. At different time points, 1 ml was removed
and diluted 1:100 in PBS. The sample was then analysed by ﬂow cytometry with a
FACSCanto A (BD Biosciences). The FITC ﬁlter was used for the detection of
positive cells. The incident light was at 488 nm for forward scatter (FSC), side
scatter (SSC) and ﬂuorescence. Detection for SSC and ﬂuorescence was at
488±10 nm and 530±30 nm, respectively. The threshold parameters were 200 for
both FSC and SSC. The PMT voltage settings were 525 (FSC), 403 (SSC) and 600
(FITC). The ﬂow rate was set to ‘low’. For each sample 30,000 events were
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collected. Reactions were repeated three times on three separate days. Data were
analysed using FlowJo software (TreeStar, USA).
Samples were also evaluated by RT–qPCR. Here, the dialyzed vesicles and E. coli
were incubated as described above for 4 h at 37 C. Subsequently, the total RNA
was extracted with the RNeasy Mini kit (Qiagen). A quantity of 10 ml of 500 ng of
RNA was reverse transcribed using RevertAid Reverse Transcriptase (Thermo
Scientiﬁc). cDNA was quantiﬁed with a CFX96 Touch real-time PCR (Bio-Rad)
with SYBR green detection. Each sample was diluted to 5 ng and measured in
triplicate in a 96 wells plate (Bio-Rad) in a reaction mixture containing
SsoAdvanced SYBR green supermix (Bio-Rad) and 180 nM of each primer in a
10ml ﬁnale volume. The primers used to quantify lacZ, lacY and lacA expression
were lacZ FW: 50-TACGATGCGCCCATCTACAC-30 , lacZ REV: 50-AACAACCC
GTCGGATTCTCC-30 , lacY FW: 50-GGTTTCCAGGGCGCTTATCT-30, lacY
REV: 50-TTCATTCACCTGACGACGCA-30 , lacA FW: 50-GCGTCACCATC
GGGGATAAT-30 , lacA REV: 50-CCACGACGTTTGGTGGAATG-30 . Gene
expression was normalized to the expression of idnT39 with the following primers:
50-CTGCCGTTGCGCTGTTTATT-30 and 50-GATTTGCTCGATGGTGCGTC-30 .
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